WHO cognitive decline and dementia guideline cites three Cochrane Reviews

It features evidence from reviews of the Cochrane Dementia and Cognitive group in 3 of the guideline’s  evidence profiles - Physical activity interventions, Management of diabetes and Management of dyslipidaemia.

The World Health Organization's latest guideline on risk reduction of cognitive decline and dementia has been published. This guideline provides global, evidence-informed recommendations on how to reduce the risk of cognitive decline and dementia.

It features evidence from reviews of the Cochrane Dementia and Cognitive Improvement group in 3 of the guideline’s  evidence profiles - Physical activity interventions, Management of diabetes and Management of dyslipidaemia. The featured reviews are:

Cochrane Dementia and Cognitive Improvement remit includes producing systematic reviews of both global cognitive impairment and focal cognitive impairments occurring in the context of brain disease. We are pleased to see Cochrane evidence being highlighted in this important guideline.

 

Wednesday, May 29, 2019
Share/Save